Syon Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Syon Capital's PFE Position: Q3 2026 in Review
Syon Capital increased its Pfizer (PFE) stake by 5.3% in Q3 2026, buying an estimated $47.4K and bringing the position to 35,354 shares worth $1.01M. The position accounts for 0.04% of the portfolio, ranked #526.
Syon Capital first reported a position in PFE in Q3 2023 and has held it in 13 quarters since. The position peaked at $1.86M in Q4 2023. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Syon Capital held 35,354 shares of Pfizer worth $1.01M as of Q3 2026.
- Syon Capital bought 1,784 Pfizer shares in Q3 2026, an estimated $47.4K.
- Pfizer made up 0.04% of Syon Capital's portfolio in Q3 2026, its #526 holding.
- Syon Capital first reported a position in Pfizer in Q3 2023 and has held it in 13 quarters since.
- Syon Capital's Pfizer position peaked at $1.86M in Q4 2023.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Syon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.